Abstract:Background The existing literature has not examined how Chinese direct-to-consumer (DTC) genetic testing providers navigate the issues of informed consent, privacy, and data protection associated with testing services. This research aims to explore these questions by examining the relevant documents and messages published on websites of the Chinese DTC genetic test providers. Methods Using Baidu.com, the most popular Chinese search engine, we compiled the websites of providers who offer genetic testing services and analyzed available documents related to informed consent, the terms of services, and the privacy policy. The analyses were guided by the following inquiries as they applied to each DTC provider: the methods available for purchasing testing products; the methods providers used to obtain informed consent; privacy issues and measures for protecting consumers’ health information; the policy for third-party data sharing; consumers right to their data; and the liabilities in the event of a data breach. Results 68.7% of providers offer multiple channels for purchasing genetic testing products, and that social media has become a popular platform to promote testing services. Informed consent forms are not available on 94% of providers’ websites and a privacy policy is only offered by 45.8% of DTC genetic testing providers. Thirty-nine providers stated that they used measures to protect consumers’ information, of which, 29 providers have distinguished consumers’ general personal information from their genetic information. In 33.7% of the cases examined, providers stated that with consumers’ explicit permission, they could reuse and share the clients’ information for non-commercial purposes. Twenty-three providers granted consumer rights to their health information, with the most frequently mentioned right being the consumers’ right to decide how their data can be used by providers. Lastly, 21.7% of providers clearly stated their liabilities in the event of a data breach, placing more emphasis on the providers’ exemption from any liability. Conclusions Currently, the Chinese DTC genetic testing business is running in a regulatory vacuum, governed by self-regulation. The government should develop a comprehensive legal framework to regulate DTC genetic testing offerings. Regulatory improvements should be made based on periodical reviews of the supervisory strategy to meet the rapid development of the DTC genetic testing industry.

Ethical, Legal, and Social Implications of Genomics in China: A Scoping Review and Implications for Precision Public Health.

Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

Patient privacy and autonomy: a comparative analysis of cases of ethical dilemmas in China and the United States

Public perceptions of international genetic information sharing for biomedical research in China: a case study of the social media debate on the article "A Pangenome Reference of 36 Chinese Populations" published in Nature

A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States

Ethical, legal and social issues related to genetics and genomics in cancer: a scoping review and narrative synthesis

Ethical challenges related to biomedical data sharing in China: A systematic literature review

Enabling responsible public genomics

Ethical and Regulatory Challenges of Generative Artificial Intelligence in Healthcare: A Chinese Perspective

Genetic Privacy and Data Protection: A Review of Chinese Direct-to-Consumer Genetic Test Services

Publics' knowledge of, attitude to and motivation towards health-related genomics: a scoping review

A review on genetic testing]

Evaluation of Clinical Impact of Pharmacogenomics Knowledge Involved in CPIC Guidelines on Chinese Pediatric Patients

A Systematic Literature Review of Ethical Challenges Related to Medical and Public Health Data Sharing in China

Psychiatric genetics in China: achievements and challenges

Genomic Data as a National Strategic Resource: Implications for the Genomic Commons and International Data Sharing for Biomedical Research and Innovation

The forty years of medical genetics in China

Framing Ethical Concerns and Attitudes Towards Human Gene Patents in the Chinese Press

The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in China

Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds

"Informed Consent" Issue in Genetic Resource Research of Different Ethnic Groups in China